RIGEL PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
RIGEL PHARMACEUTICALS, INC. (RIGL) had Operating Leases, Future Minimum Payments, Due in Four Years of $10.48 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-02-28
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $10.48M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $10.08M.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.35M.
- 2013-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $16.15M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $10.48M 10-K · filed 2019-02-28 |
| 2017-12-31 | $10.08M 10-K · filed 2018-03-06 |
| 2014-12-31 | $1.35M 10-K · filed 2015-03-03 |
| 2013-12-31 | $16.15M 10-K · filed 2014-03-04 |
| 2012-12-31 | $15.53M 10-K · filed 2013-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |